Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study will evaluate the safety and efficacy of the human monoclonal antibody (mAb) VRC-HIVMAB060-00-AB (VRC01) in preventing HIV-1 infection among men and transgender (TG) persons who have sex with men, in North America, South America, and Switzerland.
Epistemonikos ID: fe29bd7bfdcdf35f29508dcb8fd481c774348328
First added on: May 12, 2024